Penetrium Bioscience financial statements
페니트리움바이오KRX:187660 · KOSDAQ · Healthcare₩6,970-7.56%
2026-10-02 closePenetrium Bioscience's published financial data is dated 2026-10-04. 2024 revenue was KRW 9.75B. 2024 operating profit was −KRW 15.98B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy